![Matthew Gall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Gall
Director Financiero/CFO en
TANGO THERAPEUTICS, INC.
.
Perfil
Matthew Gall is currently Chief Financial Officer at Tango Therapeutics, Inc. since 2026.
Formerly, Mr. Gall was Chief Financial Officer & Treasurer at Kalaris Therapeutics, Inc. from 2025 to 2026, Chief Financial Officer at iTeos Therapeutics, Inc. from 2020 to 2025, and Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
Education includes an undergraduate degree from Bowling Green State University and an MBA from The University of Chicago Booth School of Business.
Cargos activos de Matthew Gall
| Empresas | Cargo | Inicio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Director Financiero/CFO | 15/04/2026 |
Antiguos cargos conocidos de Matthew Gall.
| Empresas | Cargo | Fin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director Financiero/CFO | 28/08/2025 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Formación de Matthew Gall.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
21
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Bowling Green State University
 Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Gall
